P&K Skin Research Center Co. Ltd (347740) — Capital Reinvestment Ratio

Latest as of September 2025: 0.17x

P&K Skin Research Center Co. Ltd (347740) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.70 Billion) in capital expenditures (₩281.11 Million). Check tangible equity quality of P&K Skin Research Center Co. Ltd to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.17x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.70 Billion
KRW

Capital Expenditures

₩281.11 Million
KRW

Data as of

Sep 2025
Most recent filing

P&K Skin Research Center Co. Ltd Capital Reinvestment Ratio (2018–2024)

This chart tracks P&K Skin Research Center Co. Ltd's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of P&K Skin Research Center Co. Ltd.

Annual Capital Reinvestment Ratio for P&K Skin Research Center Co. Ltd (2018–2024)

Year-by-year Capital Reinvestment Ratio for P&K Skin Research Center Co. Ltd from 2018 to 2024. See 347740 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 0.07x ₩9.03 Billion ₩622.12 Million ▼ -75.5%
2023 0.28x ₩5.55 Billion ₩1.56 Billion ▲ +55.6%
2022 0.18x ₩7.51 Billion ₩1.36 Billion ▼ -50.5%
2021 0.37x ₩7.70 Billion ₩2.81 Billion ▲ +200.0%
2020 0.12x ₩8.67 Billion ₩1.05 Billion ▲ +46.0%
2019 0.08x ₩6.49 Billion ₩541.19 Million ▼ -45.8%
2018 0.15x ₩4.26 Billion ₩655.80 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow